ANNALEE ROBINSON: Open Payments
NPI 1851699722 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 63 payments from 31 companies in 2025. Trend: 2023 $1,053 · 2024 $1,203 · 2025 $1,510
Food & beverage: $1,510
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $221 |
| Merck Sharp & Dohme LLC | 4 | $111 |
| Daiichi Sankyo Inc. | 4 | $99 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| PFIZER INC. | 4 | $73 |
| Adaptive Biotechnologies Corporation | 3 | $71 |
| Gilead Sciences, Inc. | 3 | $65 |
| JAZZ PHARMACEUTICALS INC. | 2 | $63 |
| ABBVIE INC. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
Products named: ENHERTU, KEYTRUDA, AYVAKIT, clonoSEQ, OJJAARA, Trodelvy, ZEPZELCA, Epkinly.
Industry payments across GA — which companies pay providers there.
